Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-16-032158)

Filing Details

Accession Number:: 0000899243-16-032158
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-10-21 16:06:19
Reporting Period:: 2016-10-21

Filing Date:: 2016-10-21
Accepted Time:: 2016-10-21 16:06:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1175680	Cytodyn Inc.	CYDY	Pharmaceutical Preparations (2834)	753056237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532878	Nader Pourhassan	1111 Main Street, Suite 660 Vancouver WA 98660	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-10-21	15,000	$0.66	15,750	No	4	P	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	60,056	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.645 to $0.665, inclusive. The reporting person undertakes to provide to CytoDyn Inc., any security holder of CytoDyn Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein.